Clinical trial
A Multicenter Study Conducted to Evaluate the Agreement Between Fingerstick Whole Blood, Venous Whole Blood and Plasma Determined on the LumiraDx Point of Care D-Dimer and Point of Care CRP Tests to Results on the Reference Analyzer
NCT04375982 is registered in ClinicalTrials.gov with LumiraDx UK Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter Study Conducted to Evaluate the Agreement Between Fingerstick Whole Blood, Venous Whole Blood and Plasma Determined on the LumiraDx Point of Care D-Dimer and Point of Care CRP Tests to Results on the Reference Analyzer
- Lead sponsor
- LumiraDx UK Limited
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 20, 2020
- Completion date
- April 5, 2022
- Enrollment
- 111 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
embolism and thrombosis, infection, inflammation